Combined TACE with Targeted and Immunotherapy versus TACE Alone Improves DFS in HCC with MVI: A Multicenter Propensity Score Matching Study
联合靶向治疗和免疫治疗的TACE疗法较单独使用TACE疗法可改善伴有微血管侵犯的肝细胞癌患者的无病生存期:一项多中心倾向评分匹配研究
期刊:Journal of Hepatocellular Carcinoma
影响因子:3.4
doi:10.2147/JHC.S504016
Chen, Xiaokun; Wu, Xiangan; Peng, Wei; Liu, Liguo; Liu, Xiao; Wan, Xueshuai; Xu, Haifeng; Zheng, Yongchang; Zhao, Haitao; Mao, Yilei; Lu, Xin; Sang, Xinting; Chang, Xiaoyan; Zhou, Kang; Pan, Jie; Guan, Mei; Hu, Dandan; Tan, Haidong; Zhang, Yaojun; Du, Shunda